The NUVISAN group acquires a pre-clinical unit in Grafing from Merck
New Managing Director at the Grafing site
01-Jul-2016 -
NUVISAN acquires a research and development site in Grafing, Germany from its longstanding partner Merck. With the addition ofpre-clinical DMPK Services from Merck, NUVISAN passes the next phase in its realignment as a pre-clinical and clinical contract research organization (CRO).
NUVISAN ...
clinical trials
contract research
Merck
+2